missing translation for 'onlineSavingsMsg'
Learn More

Gibco™ Human FGF-basic (FGF-2/bFGF) (146 aa) Recombinant Protein, PeproTech®

Numéro de catalogue. 10018C50UG
Encompass
Modifier l'affichage
Click to view available options
Quantité:
10 μg
100 μg
250 μg
50 μg
500 μg
1 mg
6 product options available for selection
Product selection table with 6 available options. Use arrow keys to navigate and Enter or Space to select.
Numéro de catalogue. Quantité
10018C50UG 50 μg
10018C100UG 100 μg
10018C10UG 10 μg
10018C1MG 1 mg
10018C250UG 250 μg
10018C500UG 500 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 6 options available.
6 options
Numéro de catalogue. 10018C50UG Fournisseur Gibco™ Code fournisseur LS10018C50UG
Saison des économies
Afficher toutes les promotions

Pour de l'aide SVP utiliser la function de clavardage; nous envoyer un couriel à help@thermofisher.com ou appelez le service à la clientèle au 1-800-234-7437.

Recombinant Protein

Recombinant Human FGF-basic (146 a.a.) is a 16.4 kDa protein consisting of 146 amino acid residues. This product is shipped at ambient temperature. For storage, handling and reconstitution information, please see the lot-specific Certificate of Analysis

FGF2 (FGFb, fibroblast growth factor basic) belongs to the fibroblast growth factor (FGF) family, and interacts with high-affinity transmembrane receptors to influence cell proliferation and tissue neovascularization. FGF2 exists as five isoforms with distinct intracellular localizations and functions. The 18 kDa isoform is predominantly cytosolic and acts through cell surface receptors, whereas the 22, 22.5, 24 and 34 kDa isoforms are nuclear and may signal independent of transmembrane receptor pathways. In humans, the gene is located on the q arm of chromosome 4. FGF2 has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for FGF2 contains multiple polyadenylation sites, and is alternatively translated from non-AUG and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. Diseases associated with FGF2 dysfunction include Kaposi Sarcoma and corneal neovascularization.

Spécifications

Numéro d'enregistrement P09038
À utiliser avec (application) Control, Bioactivity
Formule Protein with no preservative
ID du gène (Entrez) 2247
Poids moléculaire (g/mol) 16.4 kDa
Nom Human FGF-basic (FGF-2/bFGF) (146 aa)
Méthode de purification Purified
Quantité 50 μg
Sources E. coli
Conditions de stockage -20°C
Statut réglementaire RUO
Concentration en endotoxines <1 EU/μg
Alias du gène Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin
Nom usuel FGF2
Symbole de gène FGF2
Activité biologique Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg
Type de produit Protein
Conjugué Unconjugated
Recombinant Recombinant
Séquence PALPEDGGSG AFPPGHFKDP KRLYCKNGGF FLRIHPDGRV DGVREKSDPH IKLQLQAEER GVVSIKGVCA NRYLAMKEDG RLLASKCVTD ECFFFERLES NNYNTYRSRK YTSWYVALKR TGQYKLGSKT GPGQKAILFL PMSAKS
Contenu et stockage -20°C
Activité Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg.
Système d’expression E. coli
Forme Lyophilized
Grade de qualité ou de pureté ≥ 98% by SDS-PAGE gel and HPLC analyses.
Afficher plus de résultats Afficher moins de résultats